Home/ Supplements/ Ginkgo/ Ginkgo 450 mg 8:1 Extract

Ginkgo 450 mg 8:1 Extract

product on market Capsule TerraVita Premium Collection Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Ginkgo biloba extract is researched for its potential to support cognitive function and improve blood circulation. Evidence for these effects is generally considered moderate, though results vary across clinical studies. This specific formulation provides a concentrated 8:1 extract to deliver a standardized dose of the botanical compound.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Ginkgo 450 mg 8:1 Extract
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
100
Servings
Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 120.0mg (440 products) 191 studies (A:1, B:71)

Other Ingredients

Gelatin Water
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions Take 1 capsule, 3 times daily, with meals.

Additional Information

TerraVita is an exclusive line of premium natural products that use the finest, purest and most potent ingredients in the world. TerraVita's hallmarks are the highest possible standards of purity, potency, stability and freshness. All products are prepared with the greatest quality control, from raw materials through the entire manufacturing process, right up to the moment your product is sealed for freshness and shipped to you.

Please recycle!

Metadata

Product Details

UPC / SKU0 64435 20217 0
DSLD Entry Date2023-03-22
Product TypeBotanical
FormCapsule
DSLD ID288990
Data Updated2026-04-11
Research

Research Evidence

183
Research Sources
55
Avg Quality
86
Systematic Review
78
Meta Analysis
7
Other
4
Clinical Trial
2
Rct
2
Narrative Review
2
Regulatory Source
1
Openfda Safety
A Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
B Ginkgo biloba for tinnitus
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B Ginkgo biloba for tinnitus
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
B Ginkgo biloba for prevention of dementia: a randomized controlled trial
Rct JAMA 2008 PubMed DOI
B Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis
Systematic Review Frontiers in aging neuroscience 2023 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
Systematic Review Frontiers in aging neuroscience 2020 PubMed DOI
B Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2026 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
View all evidence for Ginkgo →
Compare

Similar Products

View all Ginkgo products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.